Picture of Prostatype Genomics AB logo

PROGEN Prostatype Genomics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Prostatype Genomics Announces Strong Results For Prostatype In First Step Validation Study Of Asian Population

March 31 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * PROSTATYPE GENOMICS ANNOUNCES STRONG RESULTS FOR
PROSTATYPE® IN
FIRST STEP VALIDATION STUDY OF ASIAN POPULATION
    * RESULTS IN LINE WITH WHAT WE HAVE SEEN IN EXTERNAL
VALIDATION
STUDIES PERFORMED IN EUROPE, MEANING THAT APPROXIMATELY 1/3 OF
PATIENTS ARE RECLASSIFIED BY USING PROSTATYPE® TECHNOLOGY

Source text for Eikon:  ID:nWkr1797Dk 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))

Recent news on Prostatype Genomics AB

See all news